Adare acquires Orbis for drug discovery

By The Science Advisory Board staff writers

May 4, 2020 -- Adare Pharmaceuticals on April 30 acquired pharmaceutical technology firm Orbis Biosciences. Financial details were not disclosed. The acquisition will enhance Adare's ability to manufacture products for the global pharmaceutical, animal health, and over-the-counter markets.

The deal will boost Adare's contract development and manufacturing organization business, it said. Orbis uses a single-step manufacturing process called Precision Particle Fabrication to produce drug particles that can be dosed orally or otically or injected, Adare Pharmaceuticals said. The manufacturing process consists of three platforms: Optimµm for oral delivery, Unisun for otic delivery, and Stratµm for injectable delivery, according to Adare.

FDA issues EUA for remdesivir to treat severe COVID-19 cases
The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the investigational antiviral drug remdesivir to be used...
Trio, Ajinomoto to develop cancer therapeutic
Cancer therapeutics company Trio Pharmaceuticals and biopharmaceutical contract development and manufacturing company Ajinomoto Bio-Pharma Services have...
AMRI ups hydroxychloroquine sulfate API production
AMRI Global will boost production of hydroxychloroquine sulfate active pharmaceutical ingredients (API) due to its potential effectiveness in treating...
New STM technique could lead to purer pharmaceuticals
A research project led by chemists at the University of Warwick has revealed how ultrahigh-resolution scanning tunneling microscopy (STM) can be used...
Quotient, CytoAgents develop COVID-19 cytokine storm treatment
A new collaboration between Quotient Sciences and CytoAgents will accelerate the development of a lead COVID-19 drug candidate to human clinical trials,...

Copyright © 2020

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter